Women remain underrepresented in clinical trials, and the impact of the menstrual cycle on pharmacology is not tested. Menstrual cycle impacts have been reported for several medications, meaning that dosages can sometimes be too high or too low, and drug-induced arrhythmias are more likely. This project focuses on the development of an electrochemical sensor for the detection of female hormones. The sensor is based on biohybrid carbon nanomaterials. The measurement of hormones is helpful in clinical trials and, for example, in wastewaters, where estrogen pollution is a problem.

2022

2026